NCT00249106View on ClinicalTrials.gov

Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
HIV Infection
Interventions
BIOLOGICAL

ADVAX

Trial Locations (2)

10021

Rockefeller University Hospital, New York

14642

University of Rochester Medical Center, Rochester

Sponsors
All Listed Sponsors
lead

International AIDS Vaccine Initiative

NETWORK

collaborator

Aaron Diamond AIDS Research Center

OTHER

collaborator

University of Rochester

OTHER